{"id":"antagonist-gnrh-cetrotide","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":null,"effect":"Abdominal pain/discomfort"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Injection site reactions"}]},"_chembl":{"chemblId":"CHEMBL4303227","moleculeType":"Small molecule","molecularWeight":"951.21"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By competitively antagonizing GnRH receptors in the pituitary gland, cetrotide rapidly suppresses the release of LH and FSH without an initial flare effect. This prevents premature ovulation during controlled ovarian hyperstimulation in assisted reproductive technology cycles, allowing precise timing of oocyte retrieval.","oneSentence":"Cetrotide is a GnRH antagonist that directly blocks gonadotropin-releasing hormone receptors to suppress luteinizing hormone and follicle-stimulating hormone secretion.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:16:56.545Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (in vitro fertilization)"}]},"trialDetails":[{"nctId":"NCT06378268","phase":"NA","title":"PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-24","conditions":"Progestins Primed Ovarian Stimulation","enrollment":626},{"nctId":"NCT07340827","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)","status":"RECRUITING","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2026-02-05","conditions":"Infertility","enrollment":333},{"nctId":"NCT05326087","phase":"PHASE3","title":"Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A","status":"NOT_YET_RECRUITING","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2026-06-01","conditions":"Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Polycystic Ovarian Syndrome","enrollment":204},{"nctId":"NCT02892942","phase":"PHASE4","title":"NATural Ovarian Stimulation","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-01-13","conditions":"Infertility","enrollment":129},{"nctId":"NCT06023602","phase":"NA","title":"Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF","status":"RECRUITING","sponsor":"Northwest Women's and Children's Hospital, Xi'an, Shaanxi","startDate":"2024-02-27","conditions":"Infertility","enrollment":1338},{"nctId":"NCT03680053","phase":"NA","title":"Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF","status":"TERMINATED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-04-10","conditions":"Infertility, ART","enrollment":220},{"nctId":"NCT04414748","phase":"PHASE3","title":"Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A","status":"COMPLETED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-06-10","conditions":"Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Euploid Rate","enrollment":400},{"nctId":"NCT06868576","phase":"PHASE3","title":"PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2023-01-03","conditions":"PPOS, GnRH Antagonist, Assisted Reproductive Techniques","enrollment":328},{"nctId":"NCT02496754","phase":"NA","title":"Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2016-06","conditions":"Clinical Pregnancy Rate, Ovulation Induction, IVF","enrollment":1266},{"nctId":"NCT06812559","phase":"","title":"Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2023-12-01","conditions":"Controlled Ovarian Hyperstimulation, Polycystic Ovarian Syndrome","enrollment":100},{"nctId":"NCT05447208","phase":"PHASE3","title":"Effect of GH on the Blastocyst Euploid Rate in AMA Patients","status":"RECRUITING","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2022-08-01","conditions":"Preimplantation Genetic Testing, Growth Hormone, Age, Parental","enrollment":400},{"nctId":"NCT06778733","phase":"EARLY_PHASE1","title":"Effectiveness of Low Dose Gonadotropin Stimulation Protocol Vs High Dose Gonadotropin Protocol in Poor Responders","status":"COMPLETED","sponsor":"University of Athens","startDate":"2022-01-01","conditions":"Female Infertility","enrollment":22},{"nctId":"NCT05767086","phase":"NA","title":"Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2023-03-15","conditions":"Infertility","enrollment":297},{"nctId":"NCT02890082","phase":"PHASE2","title":"Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2014-02","conditions":"Breast Cancer","enrollment":102},{"nctId":"NCT06396390","phase":"PHASE4","title":"Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Nesta Clinic","startDate":"2024-08-01","conditions":"IVF, Fertility Issues, Infertility","enrollment":152},{"nctId":"NCT02478775","phase":"NA","title":"Dysregulation of FSH in Obesity: Functional and Statistical Analysis","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2015-07","conditions":"Obesity, Fertility","enrollment":99},{"nctId":"NCT04719000","phase":"PHASE4","title":"PErsonalized Addition of Recombinant LH in Ovarian Stimulation","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-02-04","conditions":"Infertility","enrollment":120},{"nctId":"NCT03809429","phase":"PHASE3","title":"Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2019-04-29","conditions":"Infertility, Female","enrollment":437},{"nctId":"NCT06297564","phase":"NA","title":"Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol in Assisted Reproductive Treatments","status":"COMPLETED","sponsor":"New Valley University","startDate":"2022-09-01","conditions":"Progesterone Primed Endometrial Protocol, Gonadotropin Releasing Hormone Antagonist Protocol, Assisted Reproductive Treatments","enrollment":40},{"nctId":"NCT04989348","phase":"NA","title":"Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol","status":"COMPLETED","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2021-08-04","conditions":"IVF","enrollment":240},{"nctId":"NCT04671966","phase":"PHASE4","title":"Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction","status":"UNKNOWN","sponsor":"The University of Texas at Arlington","startDate":"2018-09-13","conditions":"Heart Diseases, Left Ventricular Dysfunction","enrollment":100},{"nctId":"NCT06212102","phase":"PHASE2","title":"Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation","status":"NOT_YET_RECRUITING","sponsor":"Bedaya Hospital","startDate":"2024-02","conditions":"Infertility","enrollment":120},{"nctId":"NCT06199960","phase":"PHASE3","title":"Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2019-08-02","conditions":"Assisted Reproductive Techniques","enrollment":116},{"nctId":"NCT06191809","phase":"NA","title":"Evaluate the Effectiveness of Progestin-Primed Versus GnRH Antagonist Protocols in Vietnamese Women Undergoing In-vitro Fertilization","status":"UNKNOWN","sponsor":"Hanoi Medical University","startDate":"2023-02-14","conditions":"IVF","enrollment":200},{"nctId":"NCT04724486","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04724343","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04727684","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection","enrollment":50},{"nctId":"NCT04727671","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04447872","phase":"NA","title":"The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol","status":"UNKNOWN","sponsor":"Northwell Health","startDate":"2020-09-15","conditions":"Infertility, Diminished Ovarian Reserve, IVF","enrollment":142},{"nctId":"NCT04414761","phase":"PHASE3","title":"Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response","status":"COMPLETED","sponsor":"ShangHai Ji Ai Genetics & IVF Institute","startDate":"2020-06-04","conditions":"IVF, GnRH Antagonist, PPOS","enrollment":784},{"nctId":"NCT05951400","phase":"PHASE2, PHASE3","title":"Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist in With Expected High Ovarian Response Undergoing in Vitro Fertilization","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-08-20","conditions":"IVF, PCO","enrollment":200},{"nctId":"NCT05972902","phase":"PHASE3","title":"Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-07-15","conditions":"IVF","enrollment":387},{"nctId":"NCT04157725","phase":"PHASE4","title":"Mild Stimulation Protocol Using Clomiphene Citrate for Women With PCOS Undergoing in Vitro Fertilization","status":"UNKNOWN","sponsor":"American University of Beirut Medical Center","startDate":"2023-06-01","conditions":"PCO - Polycystic Ovaries, Infertility","enrollment":154},{"nctId":"NCT05939284","phase":"NA","title":"Progesterone-Primed Ovarian Simulation in Controlled-ovarian Simulation of Infertile PCOS Patients","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2021-06-01","conditions":"PCOS","enrollment":238},{"nctId":"NCT04616729","phase":"PHASE1, PHASE2","title":"DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-11-01","conditions":"Breast Cancer Female","enrollment":30},{"nctId":"NCT04108039","phase":"NA","title":"Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.","status":"COMPLETED","sponsor":"Fundacion Dexeus","startDate":"2019-09-25","conditions":"Infertility, IVF, Preimplantation Diagnosis","enrollment":44},{"nctId":"NCT02912988","phase":"PHASE3","title":"Letrozole in Stimulated IVF Cycles","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2018-03-01","conditions":"Subfertility","enrollment":900},{"nctId":"NCT04071574","phase":"PHASE1, PHASE2","title":"Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility","status":"COMPLETED","sponsor":"Lebanese University","startDate":"2018-02-01","conditions":"Female Infertility, Female Infertility Due to Ovulatory Disorder, Premature Ovarian Failure","enrollment":200},{"nctId":"NCT05778331","phase":"","title":"The Difference Between POSEIDON Group 3 and Group 4 as Regards IVF","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-01-10","conditions":"Infertility, Female, IVF","enrollment":340},{"nctId":"NCT05751681","phase":"NA","title":"Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2023-02-20","conditions":"Ovary Cyst, Fertility Issues","enrollment":79},{"nctId":"NCT05577806","phase":"","title":"DYG Versus Cetrorelix in Oocyte Donation","status":"COMPLETED","sponsor":"Clinica de la Mujer Medicina Reproductiva, Chile","startDate":"2017-01-01","conditions":"Infertility, Female, Fertility Disorders","enrollment":202},{"nctId":"NCT04537078","phase":"PHASE3","title":"Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":90},{"nctId":"NCT02195947","phase":"PHASE4","title":"Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"Cairo University","startDate":"2014-07","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":141},{"nctId":"NCT05112692","phase":"NA","title":"Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-11","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","enrollment":200},{"nctId":"NCT04993924","phase":"PHASE4","title":"GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2021-05-01","conditions":"IVF, Ovarian Cysts","enrollment":15},{"nctId":"NCT05071339","phase":"PHASE4","title":"GnRH Antagonist Pre-treatment for the Prevention of Asynchronous Follicular Growth","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2021-04-01","conditions":"IVF","enrollment":15},{"nctId":"NCT03876145","phase":"NA","title":"The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2016-11-12","conditions":"Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome","enrollment":120},{"nctId":"NCT04819204","phase":"NA","title":"Testosterone and Neurovascular Control in Humans","status":"UNKNOWN","sponsor":"Western University, Canada","startDate":"2021-06","conditions":"Healthy","enrollment":20},{"nctId":"NCT03291821","phase":"NA","title":"DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2017-12-01","conditions":"Infertility, Female","enrollment":136},{"nctId":"NCT03373149","phase":"PHASE2","title":"Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response","status":"UNKNOWN","sponsor":"Riyadh Fertility and Reproductive Health center","startDate":"2017-11-29","conditions":"Infertility, Female","enrollment":228},{"nctId":"NCT04094467","phase":"PHASE4","title":"Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-12-07","conditions":"Polycystic Ovary Syndrome","enrollment":150},{"nctId":"NCT04308343","phase":"NA","title":"The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-03-30","conditions":"Ectopic Pregnancy","enrollment":120},{"nctId":"NCT04268927","phase":"PHASE2","title":"Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-04-01","conditions":"Infertility","enrollment":106},{"nctId":"NCT02889380","phase":"","title":"A Retrospective Study in Chinese Good Prognosis Patients Undergoing Assisted Reproductive Technology (ART) Treatment","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2016-08-29","conditions":"Infertility","enrollment":3000},{"nctId":"NCT03996434","phase":"PHASE4","title":"Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS","status":"COMPLETED","sponsor":"ClinAmygate","startDate":"2019-07-01","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":300},{"nctId":"NCT04026282","phase":"NA","title":"To Investigate the Cumulative Live Birth Rates Using GnRH Antagonist or Agonist Protocol for COS in ART Treatment","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2018-12-27","conditions":"Sterility","enrollment":888},{"nctId":"NCT02821819","phase":"PHASE4","title":"Random-start Ovarian Stimulation in Egg-donors (ROSE)","status":"TERMINATED","sponsor":"Instituto Bernabeu","startDate":"2017-01-10","conditions":"Infertility","enrollment":15},{"nctId":"NCT02042196","phase":"EARLY_PHASE1","title":"Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2013-12","conditions":"Menopause, Aging","enrollment":100},{"nctId":"NCT04008966","phase":"PHASE4","title":"Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-07-20","conditions":"Assisted Reproduction","enrollment":160},{"nctId":"NCT03763786","phase":"PHASE4","title":"Frozen Embryo Transfer With GnRH-antagonist Trial","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2018-12-13","conditions":"Infertility","enrollment":300},{"nctId":"NCT01112358","phase":"PHASE2","title":"Lutropin Alfa in Women at Risk of Poor Response","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2005-12-07","conditions":"Ovarian Stimulation","enrollment":58},{"nctId":"NCT03484611","phase":"NA","title":"Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2013-01","conditions":"Invitro Fertilizaion","enrollment":179},{"nctId":"NCT03477929","phase":"PHASE4","title":"Cetrorelix and Ganirelix Flexible Protocol for (IVF)","status":"UNKNOWN","sponsor":"Università degli Studi 'G. d'Annunzio' Chieti e Pescara","startDate":"2017-11-15","conditions":"Infertility/Sterility","enrollment":100},{"nctId":"NCT03457233","phase":"NA","title":"The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-01-03","conditions":"Invitro Fertilization","enrollment":185},{"nctId":"NCT03118830","phase":"PHASE4","title":"Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-04-21","conditions":"Invitro Fertilization","enrollment":204},{"nctId":"NCT01402336","phase":"PHASE3","title":"GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2011-06","conditions":"Infertility, Polycystic Ovary Syndrome","enrollment":43},{"nctId":"NCT03139474","phase":"PHASE2, PHASE3","title":"Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-06-01","conditions":"Infertility, Female","enrollment":120},{"nctId":"NCT01565265","phase":"NA","title":"Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2012-04","conditions":"Female Infertility Due to Nonimplantation of Ovum, Complications Associated With Artificial Fertilization","enrollment":5},{"nctId":"NCT02820415","phase":"","title":"PGS on Blastocysts From Vitrified and Fresh Oocytes","status":"COMPLETED","sponsor":"Unità di Medicina della Riproduzione, Italy","startDate":"2014-06","conditions":"Increase the Number of Blastocyst to Biopsy for Preimplantation Genetic Testing","enrollment":60},{"nctId":"NCT02784457","phase":"PHASE2","title":"Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2014-06","conditions":"Assisted Reproduction","enrollment":84},{"nctId":"NCT01709942","phase":"PHASE3","title":"Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)","status":"COMPLETED","sponsor":"Centre for Endocrinology and Reproductive Medicine, Italy","startDate":"2012-11","conditions":"PCOS, OHSS, INFERTILITY","enrollment":80},{"nctId":"NCT01109888","phase":"PHASE1, PHASE2","title":"Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)","status":"WITHDRAWN","sponsor":"Wolfson Medical Center","startDate":"","conditions":"Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)","enrollment":""},{"nctId":"NCT02335736","phase":"PHASE2","title":"Antagonist Protocol in IVF","status":"UNKNOWN","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2015-01","conditions":"Infertility","enrollment":200},{"nctId":"NCT02333253","phase":"PHASE3","title":"Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-01","conditions":"Other Complications Associated With Artificial Fertilization","enrollment":60},{"nctId":"NCT02640976","phase":"EARLY_PHASE1","title":"Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program","status":"COMPLETED","sponsor":"Cairo University","startDate":"2013-06","conditions":"Infertility","enrollment":216},{"nctId":"NCT02461875","phase":"PHASE2","title":"Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome","status":"UNKNOWN","sponsor":"Aljazeera Hospital","startDate":"2013-05","conditions":"OHSS","enrollment":236},{"nctId":"NCT01897324","phase":"PHASE4","title":"IVF/ICSI Protocols in Poor Responders With Growth Hormone","status":"COMPLETED","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2013-07","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":287},{"nctId":"NCT01204840","phase":"PHASE2","title":"Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)","status":"COMPLETED","sponsor":"Ottawa Fertility Centre","startDate":"2010-09","conditions":"Infertility, Poor Ovarian Reserve","enrollment":38},{"nctId":"NCT02442895","phase":"","title":"Biomarkers of Ovarian Reserve and Correlation With IVF Treatments","status":"COMPLETED","sponsor":"U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti","startDate":"2014-02","conditions":"Pregnancy, Ovarian","enrollment":236},{"nctId":"NCT02437032","phase":"PHASE4","title":"Gonadotropin Type in Ovarian Stimulation","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2009-04","conditions":"Infertility","enrollment":100},{"nctId":"NCT02392520","phase":"NA","title":"Luteal Antagonist Versus Conventional Treatment in Women With Severe Early Ovarian Hyperstimulation Syndrome (OHSS)","status":"UNKNOWN","sponsor":"Eugonia","startDate":"2015-05","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":40},{"nctId":"NCT02201914","phase":"PHASE4","title":"Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF","status":"UNKNOWN","sponsor":"Bioroma","startDate":"2014-01","conditions":"Poor Responders, IVF, Clomiphene Citrate","enrollment":250},{"nctId":"NCT01616225","phase":"PHASE2, PHASE3","title":"Growth Hormone in Poor Responders to IVF Trial","status":"TERMINATED","sponsor":"Pacific Centre for Reproductive Medicine","startDate":"2012-06","conditions":"Infertility","enrollment":60},{"nctId":"NCT01109654","phase":"","title":"An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-09","conditions":"Infertility","enrollment":2175},{"nctId":"NCT01669291","phase":"NA","title":"Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation","status":"COMPLETED","sponsor":"Main Line Fertility Center","startDate":"2012-07","conditions":"Fertility","enrollment":43},{"nctId":"NCT00866034","phase":"PHASE4","title":"Cetrotide Treatment Optimization","status":"TERMINATED","sponsor":"Bart CJM Fauser","startDate":"2009-02","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection","enrollment":617},{"nctId":"NCT01225835","phase":"PHASE4","title":"Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-10","conditions":"Infertility","enrollment":124},{"nctId":"NCT01079949","phase":"PHASE2","title":"A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2007-11","conditions":"Infertility, Ovulation Induction","enrollment":93},{"nctId":"NCT01948804","phase":"PHASE4","title":"The Comparison of Effect of Four Different Treatment Protocols on IVF Outcomes in Poor Responders Undergoing in Vitro Fertilization.","status":"UNKNOWN","sponsor":"Pınar Özcan Cenksoy","startDate":"2014-01","conditions":"Poor Responders Undergoing IVF","enrollment":100},{"nctId":"NCT01268761","phase":"PHASE3","title":"GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2012-04","conditions":"Ovarian Hyperstimulation Syndrome, Effects of Gonadotropin, Oocyte Maturation","enrollment":100},{"nctId":"NCT01668056","phase":"NA","title":"Synchronization of Ovarian Stimulation for in Vitro Fertilization With Follicular Wave Emergence","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2012-01","conditions":"Infertility","enrollment":30},{"nctId":"NCT01926210","phase":"PHASE4","title":"Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders","status":"UNKNOWN","sponsor":"Huang Rui","startDate":"2013-09","conditions":"Infertility","enrollment":500},{"nctId":"NCT01888744","phase":"PHASE4","title":"Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2010-09","conditions":"Reproductive Endocrinology, Fertility, Optimal Stimulation Protocol","enrollment":120},{"nctId":"NCT00867659","phase":"NA","title":"The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors","status":"COMPLETED","sponsor":"Virginia Center for Reproductive Medicine","startDate":"2009-03","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":20},{"nctId":"NCT00633347","phase":"PHASE4","title":"Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2007-01","conditions":"Infertility","enrollment":570},{"nctId":"NCT00667758","phase":"PHASE2","title":"Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Betanien Hospital","startDate":"2008-05","conditions":"Rheumatoid Arthritis","enrollment":104},{"nctId":"NCT00883766","phase":"NA","title":"Polycystic Ovary Syndrome (PCOS) and In Vitro Fertilization (IVF): A Comparison Between Standard Long Protocol Versus an Antagonist Protocol Starting on Day 1","status":"TERMINATED","sponsor":"Fundacion Dexeus","startDate":"2009-04","conditions":"Polycystic Ovary Syndrome, In Vitro Fertilization","enrollment":172},{"nctId":"NCT01468441","phase":"NA","title":"Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days","status":"COMPLETED","sponsor":"Fertility - Assisted Fertilization Center","startDate":"2011-09","conditions":"Infertility","enrollment":96},{"nctId":"NCT01636505","phase":"PHASE3","title":"The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol","status":"UNKNOWN","sponsor":"European Hospital","startDate":"2012-09","conditions":"Embryo's Genetic and Chromosomal Quality","enrollment":200},{"nctId":"NCT01595334","phase":"NA","title":"Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity","status":"UNKNOWN","sponsor":"Southern Cross Fertility Centre","startDate":"2012-04","conditions":"Infertility","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":51,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Antagonist GnRH Cetrotide","genericName":"Antagonist GnRH Cetrotide","companyName":"Instituto Valenciano de Infertilidad, IVI VALENCIA","companyId":"instituto-valenciano-de-infertilidad-ivi-valencia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cetrotide is a GnRH antagonist that directly blocks gonadotropin-releasing hormone receptors to suppress luteinizing hormone and follicle-stimulating hormone secretion. Used for Prevention of premature luteinizing hormone surge in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology (in vitro fertilization).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}